Cargando…

Stimulated saliva composition in patients with cancer of the head and neck region

BACKGROUND: To analyse over time changes in stimulated whole saliva regarding total protein, Immunoglobulin A (IgA), and mucin type O-glycans (mostly MUC5B and MUC7) in head and neck cancer patients. METHODS: 29 dentate patients (20 men and 9 women, 59 ± 8 years) treated with curative radiation ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Almhöjd, Ulrica, Cevik-Aras, Hulya, Karlsson, Niclas, Chuncheng, Jin, Almståhl, Annica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501675/
https://www.ncbi.nlm.nih.gov/pubmed/34627217
http://dx.doi.org/10.1186/s12903-021-01872-x
_version_ 1784580735098683392
author Almhöjd, Ulrica
Cevik-Aras, Hulya
Karlsson, Niclas
Chuncheng, Jin
Almståhl, Annica
author_facet Almhöjd, Ulrica
Cevik-Aras, Hulya
Karlsson, Niclas
Chuncheng, Jin
Almståhl, Annica
author_sort Almhöjd, Ulrica
collection PubMed
description BACKGROUND: To analyse over time changes in stimulated whole saliva regarding total protein, Immunoglobulin A (IgA), and mucin type O-glycans (mostly MUC5B and MUC7) in head and neck cancer patients. METHODS: 29 dentate patients (20 men and 9 women, 59 ± 8 years) treated with curative radiation therapy and chemotherapy for cancer of the head and neck region were included. The stimulated whole salivary secretion rate was determined and saliva collected at four time-points: at pretreatment, and at 6 months, 1 and 2 years post treatment. The total protein concentration was determined spectrophotometrically by using Bicinchoninic Acid assay and Immunoglobulin A (IgA) by using ELISA technique. Glycosylation pattern of salivary mucins was determined in samples collected pre- and post treatment by using LC/MS electrospray and mucin content quantified using SDS-AgPAGE gels and PAS staining. RESULTS: Compared with pretreatment, the total protein concentration was increased already at 6 months post treatment (p < 0.01), and continued to increase up to 2 years post treatment (p < 0.001). During that period no significant changes in IgA concentration was detected. At pretreatment, the output/min of both total protein and IgA was significantly higher than at all time-points post treatment. Saliva from the cancer patients showed a low abundance/no detectable MUC7, while the MUC5B level remained, compared to saliva from a healthy control. The glycomic analysis showed that the percentage of core 2 O-glycans was increased as core 1, 3 and 4 O-glycans were decreased. The level of sialylation was higher at 6 months post treatment, while sulfation was lower. CONCLUSION: A decreased output per minute of proteins at decreased salivary secretion rate, as well as reduced sulfation of MUC5B at 6 months post treatment tended to correlate with the patients’ experience of sticky saliva and oral dryness. At 2 years post treatment, the decreased amount of IgA combined with a lowered salivary secretion rate indicate a reduced oral defense with increased risk of oral infections.
format Online
Article
Text
id pubmed-8501675
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85016752021-10-20 Stimulated saliva composition in patients with cancer of the head and neck region Almhöjd, Ulrica Cevik-Aras, Hulya Karlsson, Niclas Chuncheng, Jin Almståhl, Annica BMC Oral Health Research BACKGROUND: To analyse over time changes in stimulated whole saliva regarding total protein, Immunoglobulin A (IgA), and mucin type O-glycans (mostly MUC5B and MUC7) in head and neck cancer patients. METHODS: 29 dentate patients (20 men and 9 women, 59 ± 8 years) treated with curative radiation therapy and chemotherapy for cancer of the head and neck region were included. The stimulated whole salivary secretion rate was determined and saliva collected at four time-points: at pretreatment, and at 6 months, 1 and 2 years post treatment. The total protein concentration was determined spectrophotometrically by using Bicinchoninic Acid assay and Immunoglobulin A (IgA) by using ELISA technique. Glycosylation pattern of salivary mucins was determined in samples collected pre- and post treatment by using LC/MS electrospray and mucin content quantified using SDS-AgPAGE gels and PAS staining. RESULTS: Compared with pretreatment, the total protein concentration was increased already at 6 months post treatment (p < 0.01), and continued to increase up to 2 years post treatment (p < 0.001). During that period no significant changes in IgA concentration was detected. At pretreatment, the output/min of both total protein and IgA was significantly higher than at all time-points post treatment. Saliva from the cancer patients showed a low abundance/no detectable MUC7, while the MUC5B level remained, compared to saliva from a healthy control. The glycomic analysis showed that the percentage of core 2 O-glycans was increased as core 1, 3 and 4 O-glycans were decreased. The level of sialylation was higher at 6 months post treatment, while sulfation was lower. CONCLUSION: A decreased output per minute of proteins at decreased salivary secretion rate, as well as reduced sulfation of MUC5B at 6 months post treatment tended to correlate with the patients’ experience of sticky saliva and oral dryness. At 2 years post treatment, the decreased amount of IgA combined with a lowered salivary secretion rate indicate a reduced oral defense with increased risk of oral infections. BioMed Central 2021-10-09 /pmc/articles/PMC8501675/ /pubmed/34627217 http://dx.doi.org/10.1186/s12903-021-01872-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Almhöjd, Ulrica
Cevik-Aras, Hulya
Karlsson, Niclas
Chuncheng, Jin
Almståhl, Annica
Stimulated saliva composition in patients with cancer of the head and neck region
title Stimulated saliva composition in patients with cancer of the head and neck region
title_full Stimulated saliva composition in patients with cancer of the head and neck region
title_fullStr Stimulated saliva composition in patients with cancer of the head and neck region
title_full_unstemmed Stimulated saliva composition in patients with cancer of the head and neck region
title_short Stimulated saliva composition in patients with cancer of the head and neck region
title_sort stimulated saliva composition in patients with cancer of the head and neck region
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501675/
https://www.ncbi.nlm.nih.gov/pubmed/34627217
http://dx.doi.org/10.1186/s12903-021-01872-x
work_keys_str_mv AT almhojdulrica stimulatedsalivacompositioninpatientswithcanceroftheheadandneckregion
AT cevikarashulya stimulatedsalivacompositioninpatientswithcanceroftheheadandneckregion
AT karlssonniclas stimulatedsalivacompositioninpatientswithcanceroftheheadandneckregion
AT chunchengjin stimulatedsalivacompositioninpatientswithcanceroftheheadandneckregion
AT almstahlannica stimulatedsalivacompositioninpatientswithcanceroftheheadandneckregion